Data / Research funding / Ataxia Telangiectasia
Ataxia Telangiectasia: 23 NIH awards ($18.3M) to 18 organizations
23 NIH awards ($18.3M) in the NIH spending category Ataxia Telangiectasia, to 18 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
23 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Targeting ATM to boost systemic effects of radiotherapy and immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $2,585,426 | March 9, 2021 | February 28, 2026 | ZHANG, JENNIFER YUNYAN | reporter.nih.gov |
| Structural Mechanisms of DNA Damage Sensing and Activation of the ATR, Fanconi Anemia, and ATM Checkpoints | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,017,785 | August 1, 2023 | April 30, 2027 | PAVLETICH, NIKOLA P | reporter.nih.gov |
| Mechanisms of DNA damage induced emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,827,951 | July 15, 2014 | May 31, 2025 | ARMANIOS, MARY Y | reporter.nih.gov |
| Origins of DNA damage driving pathology in human neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,507,453 | February 10, 2022 | January 31, 2027 | PAULL, TANYA T | reporter.nih.gov |
| Development of real-world motor outcome measures in ataxia-telangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,275,758 | December 15, 2023 | November 30, 2028 | GUPTA, ANOOPUM SATYAWAN | reporter.nih.gov |
| The role of ATM in the suppression of lymphoid malignancy | NIH | National Cancer Institute | 2021 to 2025 | $1,239,512 | March 1, 2011 | July 31, 2029 | ZHA, SHAN | reporter.nih.gov |
| Defining cerebellar pathophysiology in Ataxia Telangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,223,426 | January 15, 2024 | December 31, 2028 | MATHEWS, PAUL JAMES | reporter.nih.gov |
| Defining the mechanistic basis of ATM’s impact on VDJ recombination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,162,500 | May 20, 2019 | April 30, 2026 | MEEK, KATHERYN D | reporter.nih.gov |
| Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $837,420 | September 1, 2021 | July 31, 2026 | VISWANATHAN, PREETI | reporter.nih.gov |
| ATM and DNA Damage in the Nervous System | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $785,312 | August 1, 1998 | January 31, 2024 | MCKINNON, PETER J | reporter.nih.gov |
| Molecular Mechanisms Regulating Immunoglobulin Diversification | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $785,000 | March 1, 2019 | February 29, 2024 | VUONG, BAO Q | reporter.nih.gov |
| Functional characterization of the role of distinct domains of ATM and the impact of sequence variants on the DNA damage response | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $620,034 | August 20, 2019 | May 31, 2024 | ANDREASSEN, PAUL R | reporter.nih.gov |
| Optimizing Small Molecule Read-Through Compounds for Treating AtaxiaTelangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $508,727 | April 19, 2022 | October 31, 2024 | MATHEWS, PAUL JAMES | reporter.nih.gov |
| Molecular Mechanisms of Purkinje Cell Degeneration in Ataxia-Telangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $466,125 | April 1, 2021 | September 30, 2023 | HATTEN, MARY ELIZABETH | reporter.nih.gov |
| Gender-specific Role of ATM in the Heart | NIH | National Heart, Lung, and Blood Institute | 2021 | $423,196 | June 20, 2021 | May 31, 2025 | SINGH, KRISHNA | reporter.nih.gov |
| Non-genotoxic HSCT for ATM | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $234,750 | September 1, 2024 | August 31, 2026 | CHANDRAKASAN, SHANMUGANATHAN | reporter.nih.gov |
| Methods to Improve Clinical Trials for A-T | NIH | National Center for Advancing Translational Sciences | 2021 | $188,025 | June 25, 2020 | May 31, 2023 | LEDERMAN, HOWARD M. | reporter.nih.gov |
| Single-cell genetic analysis of the pathogenic role of neuronal genomic instability in environmental toxicant exposure | NIH | National Institute of Environmental Health Sciences | 2021 | $182,500 | September 22, 2020 | August 31, 2023 | LU, XIAOHONG | reporter.nih.gov |
| Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $141,408 | March 13, 2023 | January 12, 2026 | WESTOVER, KATHERINE R. | reporter.nih.gov |
| Non-canonical roles for ATM kinase in regulating mitochondrial function and redox homeostasis | NIH | National Cancer Institute | 2022 to 2024 | $126,223 | June 1, 2022 | May 31, 2025 | BURRELL, PAIGE ELIZABETH | reporter.nih.gov |
| Nucleolar signaling in cancer | NIH | National Cancer Institute | 2021 | $80,500 | December 15, 2019 | November 30, 2022 | PESTOV, DIMITRI G | reporter.nih.gov |
| Mechanisms of ATM activation by the MRN complex and DNA Double Strand Breaks | NIH | National Cancer Institute | 2021 | $62,261 | February 1, 2020 | December 20, 2021 | WARREN, CHRISTOPHER | reporter.nih.gov |
| Single-Cell Analysis of Somatic Mutation Rates, Mechanisms, and Impacts in Human Ataxia Telangiectasia Cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $34,454 | May 1, 2025 | October 31, 2028 | CLASS, BRADLEY | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 10 | $3,566,028 | 0 | $0 |
| 2024 | 11 | $4,019,241 | 0 | $0 |
| 2023 | 8 | $2,742,560 | 0 | $0 |
| 2022 | 9 | $3,348,584 | 0 | $0 |
| 2021 | 14 | $4,639,333 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.